openPR Logo
Press release

New Release | Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design

New Release | Global Biosimilar Pipeline and Market Prospects:

Researchmoz added Most up-to-date research on "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design" to its huge collection of research reports.

GBI Research’s latest report, ""Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design"" provides an in-depth assessment of the current trends in the global biosimilars market, with a particular focus on manufacturing complexities and the strategies being implemented to overcome them. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics that include data split by therapy area, stage of development, molecular target, clinical trials and company. Global revenue forecasts to 2022 for biosimilars with strong market potential, both in development and in the market, are provided.

The complex requirements of manufacturing biological drugs also apply to biosimilars, and these have been a significant barrier to the further expansion of the biosimilars market. A key challenge has been the knowledge gap under which biosimilars are developed, which arises from the fact that innovator product information remains proprietary and biosimilar manufacturers must adopt a reverse engineering process. Our new study assesses this and other significant manufacturing challenges, and how strategies based on quality initiatives and risk management can help address these issues.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1063794

Data analyses from our study show there will be enormous commercial opportunities for biosimilar developers over the coming years, given the number of high-revenue-generating biologics that will go off patent before 2020, and promising revenue forecasts for biosimilars in late-stage development. Information leveraged from our robust industry-leading database highlights a diverse number of biosimilars in the pipeline for a wide range of therapy areas, with several of these in the later stages of development. Case studies showcasing strategies adopted by leading pharmaceutical companies to compete in the biosimilars market are also provided.

Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. Our study details current biosimilar regulatory frameworks and guidelines implemented in the US, Europe, Japan and China, recent updates regarding the key issue of interchangeability, and case studies of successful biosimilar approvals in recent years.

GBI Research conducted extensive research efforts in order to provide a comprehensive view of the global biosimilar market. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

Global biosimilar pipeline in 2017
- What is the distribution of pipeline biosimilars by stage of development?
- Which are the therapy areas set to benefit the most from biosimilar drugs in development?
- In biosimilar development, what are the most common molecular targets for key therapy areas?
- How many companies are currently involved in biosimilar drug development, which are the most active and what is the level of specialization across the development landscape?

Global biosimilar clinical trials in 2017

- What was the volume of biosimilar clinical trials from 2006 to 2016, by therapy area and stage of development?
- What is the average biosimilar clinical trial size and duration across different stages of development, and across the immunology and oncology therapy areas?
- How much revenue will promising biosimilar drugs in the market, and in development, record to 2022?
- What are the key factors driving growth in the global biosimilars market?
- How important are the cost saving opportunities for national healthcare budgets?
- How much will biosimilar manufacturers benefit from the biologic drugs patent cliff?
- How does legislation regarding biosimilar interchangeability differ among key geographical markets?
- What are the factors restraining the growth of global biosimilar market?
- How do manufacturing challenges affect the market?
- What are the legal issues impacting the biosimilar market?
- How are competition and patient recruitment issues slowing growth in the market?
- What are the regulatory pathways for biosimilars in the US, Europe, Japan and China?

Manufacturing processes for biosimilar drugs

- How does molecular weight and complexity pose a challenge to biosimilar production?
- What is the impact of environmental factors on production complexity?
- How significant is the knowledge gap in the process of manufacturing a biosimilar drug?
- What are the best practice guidelines and strategies to overcome production complexities?
- How do development timelines and costs differ between biologics and biosimilars?
- What is the impact of immunogenicity in the production process?

Reasons to buy

This report will allow you to -
- Gain insightful analyses and comprehensive understanding of the global biosimilar R&D and commercial landscape
- Assess biosimilar production processes, key issues and ways to mitigate development risk
- Understand the most important driving and restraining forces in the global biosimilars market
- Learn about biosimilar strategies being adopted by leading pharmaceutical companies.
- Understand the future outlook and prospects for biosimilar drugs

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1063794

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Release | Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design here

News-ID: 521399 • Views:

More Releases for Prospects:

Potassium Iodate Market Prospects by 2024
Potassium iodate is a chemical compound majorly used in the food and healthcare industry. It is an oxidizing agent and catches fire if it comes in contact with reducing agents or combustible materials. It can be prepared by adding iodine to a hot, concentrated solution of potassium hydroxide. It can also be prepared by reacting a potassium-containing base such as potassium hydroxide with iodic acid. Read report Overview- https://www.transparencymarketresearch.com/potassium-iodate-market.html Potassium iodate is used
#Discover HARP: results and prospects
2018 was marked for Kharkov Bearing Plant by Discover HARP large presentation world tour. What is its essence? One time HARP products were supplied to over 40 countries of the world. After the collapse of the Soviet Union, the plant lost the connections with many markets for some time. In the 2000s the taken track to deep production allowed HARP not only to rebuild but also to increase the production
SaaS-Based SCM Market Growth Prospects by Key Factors, Growth Prospects, Impress …
SaaS-Based SCM market it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). The global software industry has, over the years of massive advancements and vast rise in application areas, become the backbone of a number of
09-14-2017 | Sports
Orbis Research
Sports Nutrition: Drivers and Prospects
Summary This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Sports Nutrition: Drivers and Prospects Description Consumers worldwide are adopting healthy living and fitness trends, especially across developed markets where healthy lifestyles have become the new normal. This is correspondingly expanding the consumer base for sports nutrition products, but to succeed in this new world, firms need
Promising Prospects for BPOut
After the announcement of BPOut’s participation in the A350 Electrical engineering project, further projects have been extended and several project teams expanded. At first, the collaboration on the Dubai Airport project has been confirmed to continue until at least the end of the year. The scope of this project is subcontracting management for the baggage handling systems. The satisfaction of the customer with BPOut’s results in a new field of activity
Prospects of impressive levels
Frontier Markets - a term many investors have come across in the past few years, but to most it remains just as they saw it first- a “term”. Frontier Markets are the new “in” thing in the business world; one could call them a new “breed” of investment opportunities where the condition of the market is somewhere below the “emerging” stage, but that is more than compensated by the huge